Last Posted: Nov 08, 2019
- The benefits of genetic addiction risk score (GARS™) and pro-dopamine regulation in combating suicide in the American Indian population.
Blum Kenneth et al. Journal of systems and integrative neuroscience 2018 Sep 4 - Polygenic Prediction of Substance Use Disorders in Clinical and Population Samples
PB Barr et al, BioRXIV, August 2019 - Using Machine Learning to Classify Individuals With Alcohol Use Disorder Based on Treatment Seeking Status.
Lee Mary R et al. EClinicalMedicine 2019 Jul 1270-78 - Pharmacogenetics of alcohol use disorder treatments: an update.
Hartwell Emily E et al. Expert opinion on drug metabolism & toxicology 2019 Jun - Using Smartphone Survey Data and Machine Learning to Identify Situational and Contextual Risk Factors for HIV Risk Behavior Among Men Who Have Sex with Men Who Are Not on PrEP.
Wray Tyler B et al. Prevention science : the official journal of the Society for Prevention Research 2019 May - Cost-Effectiveness Analysis of Genotype-Guided Treatment Allocation in Patients with Alcohol Use Disorders Using Naltrexone or Acamprosate, Using a Modeling Approach.
Sluiter Reinier L et al. European addiction research 2018 24(5) 245-254 - ANCO-GeneDB: annotations and comprehensive analysis of candidate genes for alcohol, nicotine, cocaine and opioid dependence.
Hu Ruifeng et al. Database : the journal of biological databases and curation 2018 2018 - From Homer and Hippocrates to modern personalized medicine: is there a role for pharmacoepigenomics in the treatment of alcohol addiction?
Ragia Georgia et al. Pharmacogenomics 2018 19(6) 513-516 - Most Current Smokers Desire Genetic Susceptibility Testing and Genetically-Efficacious Medication.
Chiu Ami et al. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2018 Oct - Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers.
Zastrozhin Michael S et al. Human psychopharmacology 2018 Oct e2677
.png)
No hay comentarios:
Publicar un comentario